Covishield Vaccine Details - Summary
This content provides essential information about the Covishield vaccine details and its significance. The Covishield vaccine is designed for individuals aged 18 years and older to prevent coronavirus disease 2019 (COVID-19). It has received a restricted use license for emergency situations, making it a critical tool to combat the COVID-19 pandemic.
The COVISHIELD™ vaccine effectively protects against COVID-19 caused by the SARS-CoV-2 virus. Its emergency approval ensures that adults aged 18 and above can potentially avoid contracting the COVID-19 disease.
To receive the Covishield vaccine, individuals must take two doses of 0.5 ml each. The second dose is ideally given between 4 to 6 weeks after the first dose. However, observations from other countries suggest that the second dose can be administered up to 12 weeks later.
Current clinical trials indicate that the COVISHIELD™ vaccine effectively prevents COVID-19 if both doses are received within 4 to 12 weeks. The exact duration of protection following vaccination remains unclear. However, a protective immune response may begin developing approximately 4 weeks after receiving the second dose of the COVISHIELD™ vaccine.
Side Effects of the COVISHIELD Vaccine
Common Reactions
Very Common (may affect more than 1 in 10 people):
- Tenderness, pain, warmth, redness, itching, swelling, or bruising at the injection site
- Feeling unwell or experiencing fatigue
- Chills, feeling feverish, or having a headache
- Nausea or feeling sick
- Joint pain or muscle ache
Common (may affect up to 1 in 10 people):
- A lump at the injection site
- Fever
- Vomiting
- Flu-like symptoms, such as high temperature, sore throat, runny nose, cough, and chills
Uncommon (may affect up to 1 in 100 people):
- Dizziness or decreased appetite
- Abdominal pain
- Enlarged lymph nodes, excessive sweating, itching, or rash
Please note that these may not be all the possible side effects of the COVISHIELD vaccine. Serious and unexpected side effects may occur, as the COVISHIELD vaccine is still being studied in clinical trials.
For more details, you can download the Covishield Vaccine Details in PDF format using the link given below.
